NYSE · CIK 0000313616
DHR DANAHER CORP /DE/
Insider trading from SEC Form 4. Last filing Mar 5, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
20
with a Form 4 at this company
Signals
Open-market buys and sells at DANAHER CORP /DE/, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 18Weak | sell 2 | SPOON ALAN G director | $114k | 550 | -0% | - | |
| 38Weak | sell 2 | Ellis Brian W Senior Vice President - GC | $1.3M | 5,700 | -22% | - | |
| 45Moderate | sell | Raskas Daniel SVP - Corporate Development | $8.2M | 34,688 | -147% | - |
Congressional trades
26 trades in DHR disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Kevin Hern House · R-OK | Sale | DHR Danaher Corporation Common Stock | $15k to $50k | Aug 31, 2026 | 25 days after the trade |
| Kevin Hern House · R-OK | Partial sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Sep 2, 2026 | 23 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| Julie Johnson House · D-TX | Sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Dec 18, 2025 | 28 days after the trade |
| Julia Letlow House · R-LA | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Apr 28, 2025 | 260 days after the trade |
| Julie Johnson House · D-TX | Partial sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Nov 13, 2025 | 28 days after the trade |
| Julie Johnson House · D-TX | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Oct 7, 2025 | 38 days after the trade |
| Lisa C. McClain House · R-MI | Sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Sep 25, 2025 | 27 days after the trade |
| Thomas H. Kean, Jr. House · R-NJ | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Sep 3, 2025 | 41 days after the trade |
| Val T. Hoyle House · D-OR | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Oct 29, 2024 | 318 days after the trade |
| Sheldon Whitehouse Senate · D-RI | Sale | DHR Danaher Corp | $1,001 to $15k | Aug 28, 2025 | 6 days after the trade |
| Lisa C. McClain House · R-MI | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Jul 22, 2025 | 22 days after the trade |
| Thomas H. Kean, Jr. House · R-NJ | Purchase | DHR Danaher Corporation Common Stock | $1,001 to $15k | Jun 11, 2025 | 35 days after the trade |
| Jefferson Shreve House · R-IN | Sale | DHR Danaher Corporation Common Stock | $15k to $50k | May 12, 2025 | 41 days after the trade |
| Jefferson Shreve House · R-IN | Purchase | DHR Danaher Corporation Common Stock | $15k to $50k | May 8, 2015 | 3,698 days after the trade |
| Pete Sessions House · R-TX | Sale | DHR Danaher Corporation Common Stock | $50k to $100k | Jun 12, 2025 | 9 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | May 15, 2025 | 16 days after the trade |
| Dan Newhouse House · R-WA | Partial sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Apr 11, 2025 | 35 days after the trade |
| Bruce Westerman House · R-AR | Sale | DHR Danaher Corporation Common Stock | $1,001 to $15k | Apr 21, 2025 | 21 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Purchase | DHR Danaher Corporation Common Stock | $15k to $50k | Apr 8, 2025 | 30 days after the trade |
Transactions
The last 71 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2025 | GRAY R BRADLEY SVP Strategic Development | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +6 | $222.74 | $1,336 | 6 | Mar 5, 2025 |
| Mar 1, 2025 | Bouda Christopher VP, Chief Accounting Officer | AGrant or award Common Stock | +1,264 | $0.00 | $0 | 8,460 | Mar 4, 2025 |
| Mar 1, 2025 | Blair Rainer President & CEO | AGrant or award Employee stock option (right to buy)derivative | +114,143 | $0.00 | $0 | 114,143 | Mar 4, 2025 |
| Mar 1, 2025 | Lamanna Charles W director | AGrant or award Common Stock | +102 | $0.00 | $0 | 102 | Mar 4, 2025 |
| Mar 1, 2025 | Riley Christopher Paul Executive Vice President | AGrant or award Common Stock | +12,034 | $0.00 | $0 | 23,183 | Mar 4, 2025 |
| Mar 1, 2025 | Sawyer Montgomery Julie A Executive Vice President | AGrant or award Common Stock | +12,034 | $0.00 | $0 | 16,918 | Mar 4, 2025 |
| Mar 1, 2025 | Ellis Brian W Senior Vice President - GC | AGrant or award Employee stock option (right to buy)derivative | +18,910 | $0.00 | $0 | 18,910 | Mar 4, 2025 |
| Mar 1, 2025 | McGrew Matthew EVP & Chief Financial Officer | AGrant or award Employee stock option (right to buy)derivative | +30,943 | $0.00 | $0 | 30,943 | Mar 4, 2025 |
| Mar 1, 2025 | GRAY R BRADLEY SVP Strategic Development | AGrant or award Employee stock option (right to buy)derivative | +17,191 | $0.00 | $0 | 17,191 | Mar 4, 2025 |
| Mar 1, 2025 | Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer | FTax withholding Common Stock | -216 | $207.76 | $45k | 12,156 | Mar 4, 2025 |
| Mar 1, 2025 | Couchara Georgeann SVP, Human Resources | FTax withholding Common Stock | -111 | $207.76 | $23k | 3,904 | Mar 4, 2025 |
| Mar 1, 2025 | Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer | AGrant or award Employee stock option (right to buy)derivative | +24,067 | $0.00 | $0 | 24,067 | Mar 4, 2025 |
| Mar 1, 2025 | Couchara Georgeann SVP, Human Resources | AGrant or award Employee stock option (right to buy)derivative | +17,191 | $0.00 | $0 | 17,191 | Mar 4, 2025 |
| Mar 1, 2025 | Sawyer Montgomery Julie A Executive Vice President | AGrant or award Employee stock option (right to buy)derivative | +24,067 | $0.00 | $0 | 24,067 | Mar 4, 2025 |
| Mar 1, 2025 | Riley Christopher Paul Executive Vice President | AGrant or award Employee stock option (right to buy)derivative | +24,067 | $0.00 | $0 | 24,067 | Mar 4, 2025 |
| Mar 1, 2025 | Lamanna Charles W director | AGrant or award Director stock option (right to buy)derivative | +290 | $0.00 | $0 | 290 | Mar 4, 2025 |
| Mar 1, 2025 | Bouda Christopher VP, Chief Accounting Officer | FTax withholding Common Stock | -74 | $207.76 | $15k | 8,386 | Mar 4, 2025 |
| Mar 1, 2025 | Sawyer Montgomery Julie A Executive Vice President | AGrant or award Employee stock option (right to buy)derivative | +34,381 | $0.00 | $0 | 34,381 | Mar 4, 2025 |
| Mar 1, 2025 | Riley Christopher Paul Executive Vice President | AGrant or award Employee stock option (right to buy)derivative | +34,381 | $0.00 | $0 | 34,381 | Mar 4, 2025 |
| Mar 1, 2025 | Bouda Christopher VP, Chief Accounting Officer | AGrant or award Employee stock option (right to buy)derivative | +3,610 | $0.00 | $0 | 3,610 | Mar 4, 2025 |
| Feb 24, 2025 | Bouda Christopher VP, Chief Accounting Officer | FTax withholding Common Stock | -285 | $211.14 | $60k | 7,196 | Feb 25, 2025 |
| Feb 24, 2025 | Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer | FTax withholding Common Stock | -586 | $211.14 | $124k | 12,372 | Feb 25, 2025 |
| Feb 24, 2025 | Riley Christopher Paul Executive Vice President | FTax withholding Common Stock | -348 | $211.14 | $73k | 11,149 | Feb 25, 2025 |
| Feb 24, 2025 | Sawyer Montgomery Julie A Executive Vice President | FTax withholding Common Stock | -618 | $211.14 | $130k | 4,884 | Feb 25, 2025 |
| Feb 24, 2025 | Couchara Georgeann SVP, Human Resources | FTax withholding Common Stock | -197 | $211.14 | $42k | 4,015 | Feb 25, 2025 |
| Feb 7, 2025 | SPOON ALAN G director | MOption exercise Common Stock | +3,928 | $59.34 | $233k | 121,068 | Feb 10, 2025 |
| Feb 7, 2025 | SPOON ALAN G director | SOpen-market sale Common Stock | -550 | $206.46 | $114k | 120,518 | Feb 10, 2025 |
| Feb 7, 2025 | SPOON ALAN G director | MOption exercise Director stock option (right to buy)derivative | -3,928 | $0.00 | $0 | 0 | Feb 10, 2025 |
| Jan 31, 2025 | Zerhouni Elias A. director | AGrant or award Phantom sharesderivative | +186 | $222.74 | $42k | 17,374 | Feb 4, 2025 |
| Jan 31, 2025 | Sanders A Shane director | AGrant or award Phantom sharesderivative | +142 | $222.74 | $32k | 1,952 | Feb 4, 2025 |
| Jan 31, 2025 | Stevens Raymond C director | AGrant or award Phantom sharesderivative | +148 | $222.74 | $33k | 6,384 | Feb 4, 2025 |
| Jan 31, 2025 | SPOON ALAN G director | AGrant or award Phantom sharesderivative | +201 | $222.74 | $45k | 29,754 | Feb 4, 2025 |
| Jan 31, 2025 | FILLER LINDA director | AGrant or award Phantom sharesderivative | +11 | $222.74 | $2,390 | 8,862 | Feb 4, 2025 |
| Jan 31, 2025 | Dewan Feroz director | AGrant or award Phantom sharesderivative | +142 | $222.74 | $32k | 1,378 | Feb 4, 2025 |
| Jan 31, 2025 | List Teri director | AGrant or award Phantom sharesderivative | +9 | $222.74 | $2,049 | 7,596 | Feb 4, 2025 |
| Feb 1, 2025 | Couchara Georgeann SVP, Human Resources | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +420 | $222.74 | $94k | 1,482 | Feb 4, 2025 |
| Feb 1, 2025 | Sawyer Montgomery Julie A Executive Vice President | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +281 | $222.74 | $63k | 1,667 | Feb 4, 2025 |
| Feb 1, 2025 | Gutierrez-Ramos Jose-Carlos SVP, Chief Science Officer | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +241 | $222.74 | $54k | 1,172 | Feb 4, 2025 |
| Feb 1, 2025 | Bouda Christopher VP, Chief Accounting Officer | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +171 | $222.74 | $38k | 2,630 | Feb 4, 2025 |
| Feb 3, 2025 | RALES MITCHELL P Chairman of Exec. Committee | AGrant or award Danaher deferred contribution programs - Danaher Stock Fundderivative | +14 | $222.74 | $3,118 | 6,425 | Feb 4, 2025 |
| Feb 3, 2025 | McGrew Matthew EVP & Chief Financial Officer | FTax withholding Common Stock | -9,345 | $214.26 | $2.0M | 20,062 | Feb 4, 2025 |
| Feb 3, 2025 | Ellis Brian W Senior Vice President - GC | FTax withholding Common Stock | -5,677 | $214.26 | $1.2M | 14,553 | Feb 4, 2025 |
| Feb 3, 2025 | Raskas Daniel SVP - Corporate Development | FTax withholding Common Stock | -4,701 | $214.26 | $1.0M | 10,524 | Feb 4, 2025 |
| Feb 3, 2025 | Riley Christopher Paul Executive Vice President | FTax withholding Common Stock | -3,074 | $214.26 | $659k | 11,497 | Feb 4, 2025 |
| Feb 3, 2025 | Blair Rainer President & CEO | FTax withholding Common Stock | -20,030 | $214.26 | $4.3M | 47,188 | Feb 4, 2025 |
| Feb 1, 2025 | Ellis Brian W Senior Vice President - GC | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +240 | $222.74 | $53k | 6,674 | Feb 4, 2025 |
| Feb 1, 2025 | Riley Christopher Paul Executive Vice President | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +341 | $222.74 | $76k | 4,466 | Feb 4, 2025 |
| Feb 1, 2025 | Raskas Daniel SVP - Corporate Development | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +721 | $222.74 | $160k | 22,809 | Feb 4, 2025 |
| Feb 1, 2025 | McGrew Matthew EVP & Chief Financial Officer | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +583 | $222.74 | $130k | 5,744 | Feb 4, 2025 |
| Feb 1, 2025 | Blair Rainer President & CEO | AGrant or award Danaher Deferred Compensation Programs - Danaher Stock Fundderivative | +1,412 | $222.74 | $314k | 15,728 | Feb 4, 2025 |
| Jan 30, 2025 | Ellis Brian W Senior Vice President - GC | MOption exercise Common Stock | +5,700 | $58.59 | $334k | 25,930 | Jan 31, 2025 |
| Jan 30, 2025 | Ellis Brian W Senior Vice President - GC | SOpen-market sale Common Stock | -5,700 | $224.13 | $1.3M | 20,230 | Jan 31, 2025 |
| Jan 30, 2025 | Ellis Brian W Senior Vice President - GC | MOption exercise Employee stock option (right to buy)derivative | -5,700 | $0.00 | $0 | 7,109 | Jan 31, 2025 |
| May 27, 2022 | FILLER LINDA director | GGift Common Stock | -21,590 | $0.00 | $0 | 22,846 | Dec 19, 2024 |
| Nov 25, 2024 | Raskas Daniel SVP - Corporate Development | SOpen-market sale Common Stock | -8,370 | $238.00 | $2.0M | 15,225 | Nov 27, 2024 |
| Nov 26, 2024 | Raskas Daniel SVP - Corporate Development | MOption exercise Common Stock | +26,318 | $58.59 | $1.5M | 41,543 | Nov 27, 2024 |
| Nov 26, 2024 | Raskas Daniel SVP - Corporate Development | SOpen-market sale Common Stock | -26,318 | $236.59 | $6.2M | 15,225 | Nov 27, 2024 |
| Nov 26, 2024 | Raskas Daniel SVP - Corporate Development | MOption exercise Employee stock option (right to buy)derivative | -26,318 | $0.00 | $0 | 0 | Nov 27, 2024 |
| Nov 21, 2024 | McGrew Matthew EVP & Chief Financial Officer | IDiscretionary transaction Common Stockindirect: By 401(k) | +1,318 | $235.05 | $310k | 10,148 | Nov 22, 2024 |
| Nov 21, 2024 | RALES MITCHELL P Chairman of Exec. Committee | GGift Common Stock, par value $.01 | -616 | $0.00 | $0 | 1,590,228 | Nov 22, 2024 |
| Nov 21, 2024 | Bouda Christopher VP, Chief Accounting Officer | IDiscretionary transaction Common Stockindirect: By 401(k) | +75 | $235.05 | $18k | 621 | Nov 22, 2024 |
| Nov 15, 2024 | Sawyer Montgomery Julie A Executive Vice President | FTax withholding Common Stock | -265 | $230.50 | $61k | 5,502 | Nov 18, 2024 |
| Nov 15, 2024 | GRAY R BRADLEY SVP Strategic Development | AGrant or award Common Stock | +13,016 | $0.00 | $0 | 13,016 | Nov 18, 2024 |
| Oct 25, 2024 | FILLER LINDA director | AGrant or award Phantom sharesderivative | +10 | $245.39 | $2,387 | 8,851 | Oct 28, 2024 |
| Oct 25, 2024 | List Teri director | AGrant or award Phantom sharesderivative | +8 | $245.39 | $2,046 | 7,587 | Oct 28, 2024 |
| Oct 25, 2024 | Stevens Raymond C director | AGrant or award Phantom sharesderivative | +134 | $245.39 | $33k | 6,236 | Oct 28, 2024 |
| Oct 25, 2024 | Dewan Feroz director | AGrant or award Phantom sharesderivative | +129 | $245.39 | $32k | 1,237 | Oct 28, 2024 |
| Oct 25, 2024 | SPOON ALAN G director | AGrant or award Phantom sharesderivative | +183 | $245.39 | $45k | 29,552 | Oct 28, 2024 |
| Oct 25, 2024 | Sabeti Pardis C director | AGrant or award Phantom sharesderivative | +130 | $245.39 | $32k | 2,805 | Oct 28, 2024 |
| Oct 25, 2024 | Zerhouni Elias A. director | AGrant or award Phantom sharesderivative | +169 | $245.39 | $41k | 17,188 | Oct 28, 2024 |
| Oct 25, 2024 | Sanders A Shane director | AGrant or award Phantom sharesderivative | +129 | $245.39 | $32k | 1,810 | Oct 28, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Blair RainerPresident & CEO
- Bouda ChristopherVP, Chief Accounting Officer
- Couchara GeorgeannSVP, Human Resources
- Dewan Ferozdirector
- Ellis Brian WSenior Vice President - GC
- FILLER LINDAdirector
- GRAY R BRADLEYSVP Strategic Development
- Gutierrez-Ramos Jose-CarlosSVP, Chief Science Officer
- Lamanna Charles Wdirector
- List Teridirector
- McGrew MatthewEVP & Chief Financial Officer
- RALES MITCHELL PChairman of Exec. Committee
- Raskas DanielSVP - Corporate Development
- Riley Christopher PaulExecutive Vice President
- SPOON ALAN Gdirector
- Sabeti Pardis Cdirector
- Sanders A Shanedirector
- Sawyer Montgomery Julie AExecutive Vice President
- Stevens Raymond Cdirector
- Zerhouni Elias A.director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.